Novartis (NVS) Collaborates With BeiGene for Oncology Drug
Published on: Tuesday 21 December 2021
Novartis NVS recently announced that it signed an option, collaboration and license agreement with BeiGene, Ltd. BGNE for ociperlimab (BGB-A1217). Ociperlimab is a late-stage TIGIT inhibitor, a novel ...
News source: https://www.nasdaq.com/articles/novartis-nvs-collaborates-with-beigene-for-oncology-drug
